GPS Wealth Strategies Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

GPS Wealth Strategies Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-297	Closed	-$29.8K	–	1601
2025 Q3	$29.8K	Hold	297	–	–	﹤0.01%	793
2025 Q2	$24.6K	Hold	297	–	–	﹤0.01%	810
2025 Q1	$24.1K	Buy	297 +94	+46%	+$8.4K	﹤0.01%	783
2024 Q4	$18.3K	Sell	203 -325	-62%	-$31.5K	﹤0.01%	813
2024 Q3	$52.2K	Sell	528 -146	-22%	-$14.3K	0.01%	565
2024 Q2	$62.5K	Buy	674 +178	+36%	+$16K	0.01%	494
2024 Q1	$47.1K	Buy	496 +350	+240%	+$32.5K	0.01%	526
2023 Q4	$13K	Hold	146	–	–	﹤0.01%	781
2023 Q3	$10.7K	Hold	146	–	–	﹤0.01%	827
2023 Q2	$12.1K	Hold	146	–	–	﹤0.01%	810
2023 Q1	$11.1K	Buy	+146	New	+$12.1K	﹤0.01%	813
2022 Q4	–	Sell	-146	Closed	-$12K	–	1095
2022 Q3	$12K	Sell	146 -74	-34%	-$6.24K	﹤0.01%	735
2022 Q2	$16K	Hold	220	–	–	﹤0.01%	678
2022 Q1	$20K	Hold	220	–	–	﹤0.01%	594
2021 Q4	$25K	Hold	220	–	–	0.01%	544
2021 Q3	$28K	Hold	220	–	–	0.01%	511
2021 Q2	$30K	Buy	220 +146	+197%	+$19.2K	0.01%	517
2021 Q1	$10K	Buy	+74	New	+$11.1K	﹤0.01%	679

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

GPS Wealth Strategies Group's XBI Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 297 shares — an estimated $29.8K sold.

GPS Wealth Strategies Group first reported a position in XBI in Q1 2021 and held it in 18 quarters. The position peaked at $62.5K in Q2 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

GPS Wealth Strategies Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
GPS Wealth Strategies Group sold 297 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $29.8K.
GPS Wealth Strategies Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 18 quarters.
GPS Wealth Strategies Group's State Street SPDR S&P Biotech ETF position peaked at $62.5K in Q2 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.